Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of generic lercanidipine 20 mg vs ZANIDIP in healthy Thai volunteers (fasting)
TCTR20241002004Phase 1Unknown
- Sponsor
- International Bio Service
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of lercanidipine in hypertension (HTN) (2 arms), sponsored by International Bio Service. Primary endpoint: Bioequivalence assessment (AUC and Cmax). Status: unknown.
02
Drugs
lercanidipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on TCTR20241002004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20241002004.